Stockscreener 앱 받기
5.31
10.62%
0.51
전일 마감가:
$4.80
열려 있는:
$5.1
하루 거래량:
5.50M
Relative Volume:
2.54
시가총액:
$7.13M
수익:
$1.23M
순이익/손실:
$-8.26M
주가수익비율:
-1.371
EPS:
-3.8732
순현금흐름:
$-14.65M
1주 성능:
+80.00%
1개월 성능:
+65.94%
6개월 성능:
+12.03%
1년 성능:
-82.24%
1일 변동 폭
$4.80
$7.36
1주일 범위
$2.75
$7.36
52주 변동 폭
$2.01
$45.60
SINTX 테크놀로지스 Stock (SINT) Company Profile
명칭
Sintx Technologies Inc
전화
801-839-3516
주소
1885 WEST 2100 STREET, SALT LAKE CITY, UT
SINT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
5.31 | 7.13M | 1.23M | -8.26M | -14.65M | -3.8732 |
|
ABT
Abbott Laboratories
|
134.92 | 234.01B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
104.49 | 154.20B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
382.78 | 146.06B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.94 | 115.42B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.30 | 43.23B | 5.72B | 4.17B | 490.10M | 6.97 |
SINTX 테크놀로지스 Stock (SINT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-12 | 개시 | Ascendiant Capital Markets | Buy |
SINTX 테크놀로지스 주식(SINT)의 최신 뉴스
Tethon3D Buys Sintx Subsidiary to Vertically Integrate Ceramic 3D Printing Materials - 3DPrint.com
SINTX Technologies Divests TA&T To Focus On Medical Devices - Nasdaq
SINTX Technologies Sells Technology Assesment and Transfer Subsidiary to Focus on Medical Device Market - GlobeNewswire
SINTX Technologies Sells Subsidiary TA&T to Tethon Corporation, Enhancing Financial Flexibility and Focus on Medical Innovations - Nasdaq
Sintx Technologies Sells Technology Assesment And Transfer Subsidiary -February 20, 2025 at 06:15 am EST - Marketscreener.com
Strategic Pivot: How SINTX's Latest Move Transforms Its Medical Device Future - StockTitan
This Healthcare Stock Rose Sharply On USPTO Issuance - The Globe and Mail
This Penny Stock Is Surging on Patent News. Analysts Think It Gain 1,300% From Here. - TradingView
S&P 500 Edges Higher; Analog Devices Earnings Top Views - Benzinga
“Technology Stocks to Watch: CSDX, LYT, SINT, TRNR, RSLS, CYCU, TRUG Market Momentum Building” - The Globe and Mail
Stock market news: OSR Holdings +104.18%, SiNtx Technologies +53.19% among top gainers during midday trading - Business Upturn
Stock market news: OSR Holdings skyrocketed by 109.97% while Nikola plunged by 39.67% during midday trading - Business Upturn
Analyzing SINT’s current quarter earnings projections - US Post News
Dow Dips 150 Points; US Housing Starts Fall In January - Benzinga
Stock market today: OSR Holdings +190.68%, SiNtx Technologies +59.22% among top gainers in early trading - Business Upturn
SINTX Shares Are On The Rise Today: What's Going On? - Benzinga
Top Premarket Gainers -February 19, 2025 at 07:40 am EST - Marketscreener.com
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga
Sintx Technologies awarded patent on silicon nitride material by USPTO - TipRanks
SINTX Technologies, Inc. Strengthens Patent Portfolio with Issuance of U.S. Patent No. 12,239,761 for Advanced Silicon Nitride Applications in Biomedical Sector - Nasdaq
SINTX Receives Issuance of U.S. Patent for Silicon - GlobeNewswire
Breakthrough Medical Implant Patent: How SINTX is Revolutionizing Surgical Materials - StockTitan
Sintx Technologies (SINT) to Release Earnings on Tuesday - Defense World
Sintx Technologies (NASDAQ:SINT) Shares Up 4.3% – Still a Buy? - Defense World
Before You Invest, Make Sure You Check This SINTX Technologies Inc (NASDAQ: SINT) Analysis - Stocks Register
SINTX Technologies Secures Patent Allowance for Wide-Ranging Silicon Nitride Biomaterial Applications - GlobeNewswire
SINTX Secures Game-Changing Patent for Revolutionary Medical Implant Technology - StockTitan
Sintx Technologies Updates Executive Compensation Agreements - TipRanks
Sintx Technologies Appoints CEO Eric Olson to Board - TipRanks
SINT (SINTX Technologies) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Capex-to-Operating-Cash-Flow : 0.00 (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) 3-Year Revenue Growth Rate : -54.60% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) EPS without NRI : $-164.41 (TTM As of Sep. 2024) - GuruFocus.com
Stock market news: Alector down -34.47%, SiNtx Technologies -32.97% among the biggest losers during mid day trading - Business Upturn
SINT (SINTX Technologies) ROE % Adjusted to Book Value : -443.54% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) FCF Margin % : -703.27% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Momentum Rank : 1 (As of Nov. 26, 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) Cyclically Adjusted Book per Share : $15,528.10 (As of Sep. 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) Cyclically Adjusted PS Ratio : 0.01 (As of Nov. 25, 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) Cyclically Adjusted Revenue p - GuruFocus.com
SINTX Technologies (LTS:0A8S) 3-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
SINTX Technologies (LTS:0A8S) 3-Year EBITDA Growth Rate : 64.20% (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Owner Earnings per Share (TTM) : -13.28 (As of Sep. 2024) - GuruFocus.com
SINT (SINTX Technologies) Price-to-Free-Cash-Flow : N/A (As of Nov. 23, 2024) - GuruFocus.com
SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - The Manila Times
SINTX Technologies and NED Medical Partner to Advance - GlobeNewswire
SINTX Technologies and NED Medical Partner to Advance Cutting-Edge Ceramic Microsphere Medical Devices for Cancer Treatment - GlobeNewswire Inc.
Sintx Technologies (NASDAQ:SINT) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Contrast - Defense World
Sintx Technologies (NASDAQ:SINT) Stock Price Up 55.9% – Here’s Why - Defense World
Sintx Technologies Initiates Stock Repurchase Program - Yahoo Finance
SINTX Technologies Appoints Gregg R. Honigblum as Chief Strategy Officer - GlobeNewswire
SINTX 테크놀로지스 (SINT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.16%
0.10%
자본화:
|
볼륨(24시간):